» Articles » PMID: 19264908

Urinary L-type Fatty Acid-binding Protein Can Reflect Renal Tubulointerstitial Injury

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2009 Mar 7
PMID 19264908
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to elucidate the role of L-type fatty acid-binding protein (L-FABP) in renal tubulointerstitial injury using a mouse adenine-induced renal injury model. C57BL/6 mice fed excess dietary adenine for 6 weeks showed a gradual increase in levels of blood urea nitrogen (BUN). They also showed severe tubulointerstitial pathological findings, such as fibrosis and macrophage infiltration without glomerular damage, which were attenuated by treatment with either allopurinol or Y-700, a new xanthine dehydroxygenase inhibitor. Because renal expression of L-FABP is defective in C57BL/6 mice, human L-FABP transgenic mice were fed an adenine-containing diet. Transgenic mice showed lower BUN levels and lower levels of pathological injury compared with wild-type mice. On the other hand, urinary levels and renal expression of L-FABP in the adenine group was significantly increased and attenuated by treatment with either allopurinol or Y-700. Urinary L-FABP was positively correlated with BUN levels and pathological damages in the tubulointerstitium. No increases in urinary protein, albumin, or N-acetyl-beta-D-glucosaminidase levels were found for 6 weeks in any group. In conclusion, we demonstrated that urinary L-FABP levels can be used to monitor both dynamics and drug responses in a mouse adenine-induced tubulointerstitial injury model.

Citing Articles

Kinin B1 Receptor Antagonism Prevents Acute Kidney Injury to Chronic Kidney Disease Transition in Renal Ischemia-Reperfusion by Increasing the M2 Macrophages Population in C57BL6J Mice.

Estrela G, Santos R, Budu A, de Arruda A, Barrera-Chimal J, Carvalho Araujo R Biomedicines. 2023; 11(8).

PMID: 37626691 PMC: 10452634. DOI: 10.3390/biomedicines11082194.


Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis.

Zhang L, Xue S, Wu M, Dong D Front Med (Lausanne). 2022; 9:914587.

PMID: 36117980 PMC: 9479543. DOI: 10.3389/fmed.2022.914587.


Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease.

Tsukamoto S, Wakui H, Azushima K, Yamaji T, Urate S, Suzuki T Sci Rep. 2021; 11(1):16843.

PMID: 34413390 PMC: 8377123. DOI: 10.1038/s41598-021-96294-8.


Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury.

Kawakami R, Matsui M, Konno A, Kaneko R, Shrestha S, Shrestha S J Pathol. 2021; 255(4):362-373.

PMID: 34370295 PMC: 9292749. DOI: 10.1002/path.5775.


Low dose of sodium-glucose transporter 2 inhibitor ipragliflozin attenuated renal dysfunction and interstitial fibrosis in adenine-induced chronic kidney disease in mice without diabetes.

Yamato M, Kato N, Kakino A, Yamada K, Inoguchi T Metabol Open. 2020; 7:100049.

PMID: 33015603 PMC: 7520892. DOI: 10.1016/j.metop.2020.100049.


References
1.
Liangos O, Perianayagam M, Vaidya V, Han W, Wald R, Tighiouart H . Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007; 18(3):904-12. DOI: 10.1681/ASN.2006030221. View

2.
Fukunari A, Okamoto K, Nishino T, Eger B, Pai E, Kamezawa M . Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. J Pharmacol Exp Ther. 2004; 311(2):519-28. DOI: 10.1124/jpet.104.070433. View

3.
Schlesinger N . Management of acute and chronic gouty arthritis: present state-of-the-art. Drugs. 2004; 64(21):2399-416. DOI: 10.2165/00003495-200464210-00003. View

4.
Nagano N, Miyata S, Abe M, Kobayashi N, Wakita S, Yamashita T . Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int. 2006; 69(3):531-7. DOI: 10.1038/sj.ki.5000020. View

5.
Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M . Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol. 2006; 169(4):1107-17. PMC: 1780178. DOI: 10.2353/ajpath.2006.060131. View